Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nano-engineering bookkeeping

This article was originally published in The Tan Sheet

Executive Summary

The International Council on Nanotechnology (ICON) says developing best practices for handling nano-materials is hindered because efforts to catalogue practices have not systematically documented current environment, health and safety practices in some workplace settings and geographies. ICON published findings from the first of a two-phase project it commissioned by researchers at the University of California, Santa Barbara (UCSB) to catalogue how industry is managing the potential occupational safety risks posed by nano-materials. The phase 1 report, "Current Knowledge and Practices regarding Environmental Health and Safety in the Nanotechnology Workplace," comes as the drug industry and FDA discuss whether the agency has sufficient resources to regulate the development and sale of nano-engineered OTC drugs, dietary supplements and other products (1"The Tan Sheet" Oct. 16, 2006, p. 4). ICON will issue findings Nov. 13 from the second phase, an international snapshot of workplace practices in nanotech industries...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099874

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel